EP300 and diffuse large B-cell lymphoma: Alternate mechanisms were observed in four DLBCL cell lines (OCI-LY7, MD903, OCI-LY19, and SU-DHL-9) mainly through mutations in EP300, SMAD4, and APC, resulting in dysregulation of TGF-β signaling and WNT signaling pathways.